IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
Immunovant, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $32.86
+35% in 1d after detection
Post-detection moves
1h
—
1d
+35%
3d
+30%
7d
+27%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS